Iovance Biotherapeutics, Inc.
IOVA
$3.89
-$0.15-3.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.27% | -0.13% | -16.27% | 11.10% | -18.54% |
| Total Receivables | 23.50% | 11.38% | -15.51% | 2.30% | 24.34% |
| Inventory | -0.06% | 3.77% | -23.97% | 27.22% | 33.55% |
| Prepaid Expenses | 17.99% | -14.97% | -27.36% | 28.42% | 83.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.17% | 1.56% | -17.58% | 12.17% | -8.34% |
|
|
|||||
| Total Current Assets | 3.17% | 1.56% | -17.58% | 12.17% | -8.34% |
| Net Property, Plant & Equipment | 0.91% | 1.73% | 6.11% | -1.09% | -8.36% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.06% | -3.73% | 3.82% | 1.05% | -7.91% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -7.15% | -6.31% | 160.28% | -7.13% | 1.40% |
| Total Assets | 0.91% | -0.27% | -6.13% | 6.19% | -8.14% |
|
|
|||||
| Total Accounts Payable | -29.06% | -2.40% | 12.34% | 3.56% | -13.18% |
| Total Accrued Expenses | 26.30% | 6.22% | 0.73% | 3.06% | 3.33% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -30.74% | -9.78% | -15.04% | -26.34% | 11.64% |
| Total Finance Division Other Current Liabilities | 47.80% | -60.46% | 52.83% | 6.97% | 228.37% |
| Total Other Current Liabilities | 47.80% | -60.46% | 52.83% | 6.97% | 228.37% |
| Total Current Liabilities | 10.00% | -2.61% | 5.27% | 0.29% | 3.63% |
|
|
|||||
| Total Current Liabilities | 10.00% | -2.61% | 5.27% | 0.29% | 3.63% |
| Long-Term Debt | -- | -- | -- | -- | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.79% | 0.26% | 1.98% | -0.33% | -33.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.51% | -8.74% | 8.56% | -1.09% | 0.31% |
| Total Liabilities | 5.88% | -3.01% | 5.07% | -0.57% | -8.10% |
|
|
|||||
| Common Stock & APIC | 2.00% | 3.03% | 0.85% | 5.37% | 1.07% |
| Retained Earnings | -2.66% | -3.49% | -4.47% | -4.87% | -3.41% |
| Treasury Stock & Other | 2.09% | -22.80% | 231.41% | 701.72% | -106.44% |
| Total Common Equity | -0.53% | 0.54% | -9.04% | 8.09% | -8.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -33.33% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -33.33% | 0.00% |
|
|
|||||
| Total Common Equity | -0.53% | 0.54% | -9.04% | 8.09% | -8.15% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -33.33% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.53% | 0.54% | -9.04% | 8.09% | -8.15% |
|
|
|||||